Medipower (Overseas) Public Co. Limited (MDPR.TA)
ILA 649.7
(0.92%)
ILA 649.7
(0.92%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -13.5 Million USD | 30.07% |
| 2022 | -19.3 Million USD | -229.99% |
| 2021 | -5.85 Million USD | 45.92% |
| 2020 | -10.81 Million USD | -80.83% |
| 2019 | -5.98 Million USD | 9.0% |
| 2018 | -6.57 Million USD | -81.78% |
| 2017 | -3.61 Million USD | -60.83% |
| 2016 | -2.24 Million USD | 49.13% |
| 2015 | -4.42 Million USD | 39.8% |
| 2014 | -7.34 Million USD | -183.11% |
| 2013 | -2.59 Million USD | -382.42% |
| 2012 | 918.48 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -2.32 Million USD | 54.75% |
| 2023 FY | - USD | 30.07% |
| 2023 Q1 | -2.96 Million USD | 66.22% |
| 2023 Q2 | -2.17 Million USD | 26.65% |
| 2023 Q3 | -3.22 Million USD | -48.14% |
| 2023 Q4 | -5.13 Million USD | -59.13% |
| 2022 FY | - USD | -229.99% |
| 2022 Q1 | -6.04 Million USD | -250.09% |
| 2022 Q2 | -343 Thousand USD | 94.32% |
| 2022 Q3 | -2.36 Million USD | -590.09% |
| 2022 Q4 | -8.78 Million USD | -271.14% |
| 2021 Q3 | -5.99 Million USD | -106.48% |
| 2021 Q1 | -1 Million USD | 67.95% |
| 2021 Q2 | -2.9 Million USD | -188.18% |
| 2021 Q4 | 4.02 Million USD | 167.17% |
| 2021 FY | - USD | 45.92% |
| 2020 FY | - USD | -80.83% |
| 2020 Q1 | -2.62 Million USD | -861.17% |
| 2020 Q2 | -2.75 Million USD | -4.88% |
| 2020 Q3 | -2.3 Million USD | 16.39% |
| 2020 Q4 | -3.14 Million USD | -36.55% |
| 2019 Q3 | -2.6 Million USD | -66.47% |
| 2019 Q4 | -273 Thousand USD | 89.51% |
| 2019 Q1 | -1.54 Million USD | -247.56% |
| 2019 Q2 | -1.56 Million USD | -1.17% |
| 2019 FY | - USD | 9.0% |
| 2018 Q1 | -2.47 Million USD | -255.34% |
| 2018 Q3 | -1.63 Million USD | 13.22% |
| 2018 Q4 | 1.04 Million USD | 164.08% |
| 2018 FY | - USD | -81.78% |
| 2018 Q2 | -1.88 Million USD | 23.86% |
| 2017 Q4 | 1.59 Million USD | 218.81% |
| 2017 Q1 | -982 Thousand USD | -691.57% |
| 2017 FY | - USD | -60.83% |
| 2017 Q2 | -919 Thousand USD | 6.42% |
| 2017 Q3 | -1.34 Million USD | -45.81% |
| 2016 Q3 | 194 Thousand USD | 112.45% |
| 2016 Q4 | 165.99 Thousand USD | -14.43% |
| 2016 Q2 | -1.55 Million USD | -48.52% |
| 2016 Q1 | -1.04 Million USD | -8169.23% |
| 2016 FY | - USD | 49.13% |
| 2015 Q1 | -2.19 Million USD | -242.59% |
| 2015 FY | - USD | 39.8% |
| 2015 Q4 | 13 Thousand USD | 100.66% |
| 2015 Q3 | -1.97 Million USD | -157.03% |
| 2015 Q2 | -768 Thousand USD | 65.03% |
| 2014 FY | - USD | -183.11% |
| 2014 Q3 | -2.25 Million USD | -10.96% |
| 2014 Q4 | -640.99 Thousand USD | 71.6% |
| 2014 Q2 | -2.03 Million USD | 15.67% |
| 2014 Q1 | -2.41 Million USD | -147.66% |
| 2013 Q1 | -2.46 Million USD | -115.92% |
| 2013 Q3 | -1.91 Million USD | 29.81% |
| 2013 Q4 | 5.06 Million USD | 364.01% |
| 2013 FY | - USD | -382.42% |
| 2013 Q2 | -2.73 Million USD | -10.84% |
| 2012 Q4 | 15.47 Million USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|